PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Symptom | C0019196|hepatitis c |
| Sentences | 114 |
| PubMedID- 22410057 | The primary liver diseases included hepatitis b virus (n=2), alcoholic liver cirrhosis (n=2), cryptogenic liver disease (n=1), and hepatitis c virus with hepatocellular carcinoma (n=1). |
| PubMedID- 23602201 | High tumor necrosis factor-alpha/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 26508201 | Characteristics and prognosis of hepatocellular carcinoma detected in patients with chronic hepatitis c after the eradication of hepatitis c virus: a multicenter study from japan. |
| PubMedID- 21499248 | To identify the genetic susceptibility factor(s) for hepatitis c virus-induced hepatocellular carcinoma (hcv-induced hcc), we conducted a genome-wide association study using 432,703 autosomal snps in 721 individuals with hcv-induced hcc (cases) and 2,890 hcv-negative controls of japanese origin. |
| PubMedID- 21286221 | A 72-year-old japanese man underwent partial resection of the liver for hepatocellular carcinoma associated with hepatitis c viral infection. |
| PubMedID- 26446006 | Background and objectives: we studied the effect of achieving sustained virological response (svr) on the risk of developing hepatocellular carcinoma (hcc) in patients with hepatitis c receiving anti-hepatitis c virus treatment. |
| PubMedID- 25559682 | The aim of the present study was to evaluate wfa(+) -m2bp as a predictor of hepatocellular carcinoma (hcc) development in patients with chronic hepatitis c. |
| PubMedID- 26469163 | Methods: thirty consecutive cases of percutaneous arterial chemoembolization for hepatocellular carcinoma with hepatitis c-related cirrhosis(male, 23; female, 7; age, 74+/-5.9; weight, 62.7+/-12.3 kg; child-pugh a, 23; child-pugh b, 7)were analyzed retrospectively. |
| PubMedID- 22419005 | Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 24632756 | The serum level of vegf has potential to be a useful predictor of the presence of hepatocellular carcinoma in patients with hepatitis c virus (hcv)-related liver cirrhosis, while serum levels of afp and vegf can predict tumor type and vascular invasion, respectively25. |
| PubMedID- 26140089 | Aim: to evaluate the downstaging rates in hepatitis c virus-patients with hepatocellular carcinoma (hcc), treated with degradable starch microspheres transcatheter arterial chemoembolization (dsm-tace), to reach new-milan-criteria (nmc) for transplantation. |
| PubMedID- 21520203 | Occult hepatitis b virus infection and hepatocellular carcinoma development in patients with chronic hepatitis c. |
| PubMedID- 23395693 | Efficacy of interferon-based antiviral therapy on the risk of hepatocellular carcinoma of patients with chronic hepatitis c: further evidence in decompensation cirrhosis. |
| PubMedID- 22414050 | Aim: the role of interferon (ifn) therapy on prevention of hepatocellular carcinoma (hcc) in patients with hepatitis c virus (hcv)-related cirrhosis remains controversial. |
| PubMedID- 21170963 | Obesity and metabolic syndrome are recognized risk factors for development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc). |
| PubMedID- 23982634 | Effect of occult hepatitis b virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis c virus infection. |
| PubMedID- 22044490 | Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma. |
| PubMedID- 24703510 | Impact of epidermal growth factor single-nucleotide polymorphism on recurrence of hepatocellular carcinoma after hepatectomy in patients with chronic hepatitis c virus infection. |
| PubMedID- 20616578 | Impact of peginterferon maintenance therapy on the risk of developing hepatocellular carcinoma in patients with chronic hepatitis c virus. |
| PubMedID- 24677195 | hepatocellular carcinoma screening in patients with compensated hepatitis c virus (hcv)-related cirrhosis aware of their hcv status improves survival: a modeling approach. |
| PubMedID- 23701091 | Objective: the objective of our study was to describe the cross-sectional imaging appearance of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection in the absence of advanced fibrosis and cirrhosis. |
| PubMedID- 23797139 | Nonsurgical issues in lt are hepatitis c reinfection, selection of appropriate patients with hepatocellular carcinoma and individualized immunosuppression. |
| PubMedID- 21931376 | Frequency of elevated hepatocellular carcinoma (hcc) biomarkers in patients with advanced hepatitis c. |
| PubMedID- 22105231 | Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis c virus infection receiving interferon therapy: a single center study. |
| PubMedID- 21963516 | To identify the genetic susceptibility factor(s) for hepatitis c virus-induced hepatocellular carcinoma (hcv-induced hcc), we conducted a genome-wide association study using 432,703 autosomal snps in 721 individuals with hcv-induced hcc (cases) and 2890 hcv-negative controls of japanese origin. |
| PubMedID- 24409059 | Aim: to study the potential association between hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc), cirrhosis and latent hepatitis b (lhb) infection, defined as the absence of detectable serum hepatitis b surface antigen (hbsag) and the presence of hepatitis b core antibody (hbcab). |
| PubMedID- 26428254 | Non-alcoholic steato-hepatitis can progress to cirrhosis of the liver and hepatocellular carcinoma. |
| PubMedID- 25654412 | Results: there were 109 patients with hepatocellular carcinoma associated with hepatitis c virus that underwent living-donor liver transplant from july 2002 to june 2012. |
| PubMedID- 22096937 | Antiviral treatment reduces risk of hepatocellular carcinoma in patients with hepatitis c virus-related chronic hepatitis and cirrhosis. |
| PubMedID- 21718500 | Reported a correlation between a diabetic pattern of the 75 g oral glucose tolerance test ogtt and hepatocarcinogenesis and considered it a significant risk factor for hepatocellular carcinoma (hcc) in patients with hepatitis c virus . |
| PubMedID- 23426277 | Association of interleukin-28b genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis c. |
| PubMedID- 25912838 | We assessed the effects of hvpg and svr on the risk of liver decompensation, hepatocellular carcinoma, and/or death in patients with hepatitis c-related cirrhosis. |
| PubMedID- 23657093 | Untreated chronic hepatitis c can lead to cirrhosis, hepatocellular carcinoma and death 2. |
| PubMedID- 24757565 | For instance, most human hepatocellular carcinomas (hccs) result from hepatitis c virus (hcv) infection . |
| PubMedID- 21461077 | Background/aims: despite great progress, antiviral treatment for chronic hepatitis c in patients with prior hepatocellular carcinoma (hcc) has been rarely investigated. |
| PubMedID- 19879972 | Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis c virus-related cirrhosis. |
| PubMedID- 23844083 | Protein kinase r modulates c-fos and c-jun signaling to promote proliferation of hepatocellular carcinoma with hepatitis c virus infection. |
| PubMedID- 24662676 | Given the role of hepatocellular cd81 in hcv infection and the association of chronic hepatitis c with hepatocellular carcinoma (hcc) there is a growing interest in studying the function of cd81 in hepatocytes. |
| PubMedID- 25544880 | Evaluation of hepatocellular carcinoma development in patients with chronic hepatitis c by eob-mri. |
| PubMedID- 22966320 | Development of hepatocellular carcinoma in patients with chronic hepatitis c more than 10 years after sustained virological response to interferon therapy. |
| PubMedID- 23860735 | Genetic variation near interleukin 28b and the risk of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 25469280 | Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis c virus infection: a prospective study. |
| PubMedID- 22695885 | Background: there is limited literature on hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection in the absence of cirrhosis. |
| PubMedID- 20883676 | Background: there are few blood tests for an efficient detection of hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection. |
| PubMedID- 21224684 | We performed transarterial chemoembolization (tace) on the 67-year-old man who had hepatectomy for hepatocellular carcinoma with hepatitis c, recurrence in the liver and lymph nodes.the metastasis in lymph node did not show a clear increase until dying, and tace showed the possibility of one treatment method to the metastasis in lymph node of the hepatocellular carcinoma. |
| PubMedID- 24772876 | Concurrent development of non-hodgkin lymphoma and hepatocellular carcinoma in patient with chronic hepatitis c. |
| PubMedID- 22588449 | Skull metastasis from hepatocellular carcinoma with hepatitis c. |
| PubMedID- 24393884 | Case 1 involved a 63-year-old woman who had multiple hepatocellular carcinomas (hcc) associated with hepatitis c virus infection. |
| PubMedID- 23122451 | Is serum level of methylated rassf1a valuable in diagnosing hepatocellular carcinoma in patients with chronic viral hepatitis c. |
| PubMedID- 22875473 | Inhibition of hepatocellular carcinoma by pegifnalpha-2a in patients with chronic hepatitis c: a nationwide multicenter cooperative study. |